Galderma’s Breakthrough Findings Galderma (SWX:GALD), a global leader in dermatology, has announced the results of its Phase IIIb RELAX clinical trial, demonstrating the rapid onset, long-lasting efficacy, and high patient satisfaction of RelabotulinumtoxinA (Relfydess™) for treating frown lines (glabellar lines).…
KORU Medical Systems Partners on Phase III Trial for Rare Renal Disorder Treatment, Expanding Its Reach in Subcutaneous Infusion Solutions KORU Medical Systems (NASDAQ: KRMD), a leading innovator in large-volume subcutaneous infusion solutions, has announced an exciting collaboration with a…
Ferrer Achieves Compliance Leader Verification™: A Testament to Excellence in Ethics and Corporate Responsibility In a significant milestone for ethical business practices, Ferrer, a global pharmaceutical company headquartered in Barcelona, has been awarded the prestigious Compliance Leader Verification™ by Ethisphere,…
Lead Capital Partners and Petra Capital Partners Propel Lieberman’s Growth with Strategic Platform Investment In a landmark move set to bolster its position as a leader in primary market research, Lieberman, Inc., a premier research and analytics firm, has secured…
PFID Poll: Bipartisan Support for Continued Vaccine Availability and Concern Over Declining Childhood Vaccination Rates The Partnership to Fight Infectious Disease (PFID) has released the results of a public opinion poll that highlights a strong consensus among American voters on…
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company dedicated to developing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other severe conditions driven by protein growth factors, has officially submitted a Biologics License Application (BLA) to the U.S.…
JCR Pharmaceuticals to Present at the 21st Annual WORLDSymposium™ 2025 in San Diego JCR Pharmaceuticals Co., Ltd. (TSE 4552), a leading global specialty pharmaceutical company, has announced its participation in the 21st Annual WORLDSymposium™ 2025, which will take place from…
GeminiBio Appoints Matt Stober to Board of Directors Gemini Bioproducts, LLC (“GeminiBio”), a leading supplier of raw materials to the biopharmaceutical and advanced therapy industries, has announced the appointment of Matthew Stober to its Board of Directors. This strategic addition…
Sage Therapeutics Explores Strategic Alternatives and Rejects Biogen’s Acquisition Offer Sage Therapeutics, Inc. (Nasdaq: SAGE), a leader in brain health therapeutics, announced today that its Board of Directors has initiated a formal process to explore strategic alternatives for the company.…
Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, has officially launched the Ncyte® Heart in a Box, an innovative 3D model of cardiac microtissue designed to transform cardiovascular research and drug discovery. This groundbreaking system represents…
Arcus Biosciences Appoints Richard Markus, M.D., Ph.D., as Chief Medical Officer Arcus Bioscience a clinical-stage biopharmaceutical Officer company focused on developing novel molecules and combination therapies for cancer treatment, has announced the appointment of Richard Markus, M.D., Ph.D., as its…
Aseptic Filling Machine Market: Industry Trends and Global Forecasts to 2035 The global market for aseptic filling machines has witnessed remarkable growth over recent years, driven by advancements in pharmaceutical manufacturing processes, the increasing demand for biologics, and stringent regulations…